In Vivo Application of Bacteriophage as a Potential Therapeutic Agent To Control OXA-66-Like Carbapenemase-Producing Acinetobacter baumannii Strains Belonging to Sequence Type 357.
about
Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment OptionsClinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges.Characterization and Testing the Efficiency of Acinetobacter baumannii Phage vB-GEC_Ab-M-G7 as an Antibacterial Agent.Comparative Analysis of 37 Acinetobacter Bacteriophages.Phage Therapy as a Promising New Treatment for Lung Infection Caused by Carbapenem-Resistant Acinetobacter baumannii in Mice.Characterization of Two Novel Bacteriophages Infecting Multidrug-Resistant (MDR) Acinetobacter baumannii and Evaluation of Their Therapeutic Efficacy in Vivo.
P2860
In Vivo Application of Bacteriophage as a Potential Therapeutic Agent To Control OXA-66-Like Carbapenemase-Producing Acinetobacter baumannii Strains Belonging to Sequence Type 357.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
In Vivo Application of Bacteri ...... elonging to Sequence Type 357.
@en
In Vivo Application of Bacteri ...... elonging to Sequence Type 357.
@nl
type
label
In Vivo Application of Bacteri ...... elonging to Sequence Type 357.
@en
In Vivo Application of Bacteri ...... elonging to Sequence Type 357.
@nl
prefLabel
In Vivo Application of Bacteri ...... elonging to Sequence Type 357.
@en
In Vivo Application of Bacteri ...... elonging to Sequence Type 357.
@nl
P2093
P2860
P356
P1476
In Vivo Application of Bacteri ...... Belonging to Sequence Type 357
@en
P2093
Dongeun Yong
Jong-Hwan Park
Jongsoo Jeon
Jun-Young Lee
Kyungwon Lee
P2860
P304
P356
10.1128/AEM.00526-16
P407
P577
2016-06-30T00:00:00Z